A shadow market for unlicensed slimming drugs is propelled by TikTok fitness influencers and sellers on communication apps, according to new investigations.
Experimental Drug Acquiring Popularity Online
Retatrutide, which is still in research studies, is being advertised by online personalities for its supposed weight-reducing properties. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.
Thriving Trade on Social Networks
Separately, a flourishing market exists on Telegram, where communities with numerous of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors promote the substance there before directing customers to WhatsApp for transactions.
Learning About Retatrutide
Retatrutide is an investigational injection developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.
Healthcare Professionals Express Concerns
However, doctors and pharmacists have cautions that the sale of what is still an unapproved drug in the UK is worrisome and could result in individuals administering products of uncertain source.
Some experts said the demand for retatrutide could be connected to the rising price of licensed slimming treatments such as Mounjaro.
Legal Position and Implementation
Selling the unapproved drug on social media or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or distributed for human use under the Human Medicines Regulations 2012.
Several influencers try to sidestep the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a controlled substance, but promotion and distribution can still violate medicines, marketing, and consumer laws, potentially leading to penalties, legal action or imprisonment.
Service Response and Material Removal
According to the social media company, the platform has removed violative material and banned associated hashtags and query recommendations. The company stated it was committed to maintaining the platform safe and investing in strengthening enforcement strategies.
Digital Trading Activities
Investigations also found groups with up to 9,000 participants marketing the experimental drug using the platform's built-in search feature, which operates like a online catalog. Typing “retatrutide” immediately brings up channels with thousands of members, filled with photos of weight loss, positive testimonials and detailed instructions for mixing or administering at residence.
Within moments of joining one group, a vendor shared contact information, where most transactions occur. The seller provided an instruction manual and guaranteed delivery within two days. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another provided a image of a alleged testing documentation. Not one inquired about body mass, health issues or past usage.
Item Details and Costs
Inside these communities, messages display dark colored packages with postal service stickers, stating to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20 milligrams. When questioned how long a injector should last, sellers give conflicting responses varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A representative for Telegram stated it regularly moderated harmful material on its platform including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Healthcare Professional Cautions
“People are administering materials they cannot confirm. Even if the research behind this drug is valid, these online versions may not include what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of an online medical service linked the increase in demand to current cost increases for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was clean,” she explained.
Her team has previously encountered patients injured by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or communication platforms is taking chances with your well-being,” stated Wyllie. “These substances could be contaminated or incorrectly dosed.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been evaluated or authorized by any government authority globally. “Consequently at this time no one can market [it] for human use,” they said, adding that any product “misleadingly claiming itself as a company experimental substance not yet authorized … may subject users to potentially significant health risks”.
